Coronavirus

Flu cases surge in the UK hospitals while China battles human metapneumovirus

Flu Season: New data from the NHS shows rapid rise in flu cases across the UK, whilst across the world, china continues its battle against human metapneumovirus virus.

COVID-19 antibodies decline significantly one month after discharge

A new study has revealed that COVID-19 antibodies fade after only a month, which could be a devastating blow in the global race to find a vaccine.

COVID-19 and pulmonary fibrosis

Steve Jones, President of EU-IPFF and Chair, Action for Pulmonary Fibrosis in the UK describes the connection between COVID-19 and pulmonary fibrosis.

COVID-19: New study highlights the importance of social distancing

A new study shows travelling from the home is associated with significantly higher likelihood of contracting COVID-19, while strict social distancing prevents infection.

Will the ‘fast fashion’ industry recover from this pandemic?

Alessandro Brun, Politecnico di Milano School of Management, discusses the changing future of the 'fast fashion' industry.

Could disruptions such as COVID-19 bring new opportunities for business?

A new study has highlighted how businesses can use disruptive, external changes, such as the COVID-19 pandemic to their advantage.

Innovative treatments for heart failure

Prof Dr Joost Sluijter, Professor, Cellular and Translational Cardiology at University Medical Center Utrecht shares an in-depth perspective on the needs for innovative treatments for heart failure.

U-turn for health and social care: From clapping to clamping down on border control

Alex Christen, Immigration lawyer at Capital Law, investigates the future employment regulations of overseas workers in health and social care.

Using eHealth applications to improve care for patients with pulmonary fibrosis

Karen Moor and Marlies Wijsenbeek discuss how pulmonary fibrosis patients can be helped by the new possibilities of eHealth apps.

LRG1: An emerging therapeutic target for the treatment of microvascular dysfunction

John Greenwood PhD and Stephen E. Moss PhD explore the imminent potential of LRG1 as a microvascular dysfunction treatment.

Rehabilitation could reduce lung and heart damage in COVID-19 patients

Researchers have discovered that COVID-19 patients recover faster the sooner they undergo rehabilitation after leaving intensive care.

Going viral: COVID-19, environmental injustice & institutionalised racism

Bianca Yaghoobi, Tanya Khemet Taiwo, and Pamela Lein shed light on research about the COVID-19 pandemic, environmental injustice and institutionalised racism.

COVID-19 is exacerbating an already worrying plastic pollution problem

The COVID-19 pandemic has sparked a huge surge in plastic pollution, adding to an already worrying plastic waste problem that is threatening all marine life.

The European Commission’s next EU long-term budget

Johannes Hahn, European Commissioner for Budget and Administration charts his priorities for the next EU long-term budget and the impact of COVID-19 on the Union.

53% of pupils from deprived schools are four months behind, say teachers

As children in the UK return to school three months behind in their studies, a survey has suggested disadvantaged pupils and boys have been worst hit.

COVID-19: A test for democracies

Thomas Lahnthaler, CEO of The Crisis Compass, explains how COVID-19 is truly a test for democracies in this insightful piece of political analysis.

What has COVID-19 taught us about the benefits of TEC?

Gavin Bashar, UK Managing Director of Tunstall Healthcare, discusses what healthcare professionals, social care leaders and local governments have learned about the benefits of technology enabled care (TEC) amid COVID-19.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders